Novavax said on Wednesday U.S. regulators asked the company to produce more data on its COVID-19 vaccine if it gets full approval, sending the drugmaker's shares soaring and easing concerns around the ...

Q1 2025 Management View CEO John Jacobs highlighted the shift in Novavax's corporate strategy over the past year, ...

Mayank Mamtani, B. Riley Securities: Asked about BARDA correspondence, sentinel cohort learnings, and norovirus DSMB review. CMO Cummings noted, "we intend to engage with our partners at BARDA to ...

Detailed price information for Arrowhead Pharma (ARWR-Q) from The Globe and Mail including charting and trades.